|
Accr2g02045 |
717 |
SMART |
ring_2 |
31 |
68 |
IPR001841 |
- |
|
Accr2g02045 |
717 |
SMART |
ring_2 |
407 |
453 |
IPR001841 |
- |
|
Accr2g02045 |
717 |
Pfam |
BRCA1 C Terminus (BRCT) domain |
498 |
569 |
IPR001357 |
- |
|
Accr2g02045 |
717 |
Gene3D |
Zinc/RING finger domain, C3HC4 (zinc finger) |
15 |
100 |
IPR013083 |
- |
|
Accr2g02045 |
717 |
Gene3D |
BRCT domain |
605 |
710 |
IPR036420 |
- |
|
Accr2g02045 |
717 |
ProSiteProfiles |
BRCT domain profile. |
604 |
717 |
IPR001357 |
- |
|
Accr2g02045 |
717 |
ProSitePatterns |
Zinc finger RING-type signature. |
46 |
55 |
IPR017907 |
- |
|
Accr2g02045 |
717 |
PANTHER |
BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN BRCA1 |
11 |
278 |
IPR031099 |
GO:0006281|GO:0006974 |
|
Accr2g02045 |
717 |
MobiDBLite |
consensus disorder prediction |
220 |
312 |
- |
- |
|
Accr2g02045 |
717 |
ProSiteProfiles |
Extended PHD (ePHD) domain profile. |
334 |
454 |
IPR034732 |
- |
|
Accr2g02045 |
717 |
ProSiteProfiles |
BRCT domain profile. |
497 |
583 |
IPR001357 |
- |
|
Accr2g02045 |
717 |
SMART |
PHD_3 |
406 |
454 |
IPR001965 |
- |
|
Accr2g02045 |
717 |
ProSiteProfiles |
Zinc finger RING-type profile. |
31 |
69 |
IPR001841 |
- |
|
Accr2g02045 |
717 |
SUPERFAMILY |
RING/U-box |
22 |
88 |
- |
- |
|
Accr2g02045 |
717 |
CDD |
BRCT_Bard1_rpt1 |
497 |
571 |
- |
- |
|
Accr2g02045 |
717 |
Gene3D |
BRCT domain |
494 |
599 |
IPR036420 |
- |
|
Accr2g02045 |
717 |
MobiDBLite |
consensus disorder prediction |
235 |
298 |
- |
- |
|
Accr2g02045 |
717 |
Pfam |
PHD-like zinc-binding domain |
375 |
454 |
- |
- |
|
Accr2g02045 |
717 |
SUPERFAMILY |
BRCT domain |
608 |
714 |
IPR036420 |
- |
|
Accr2g02045 |
717 |
Pfam |
RING-type zinc-finger |
31 |
56 |
IPR027370 |
- |
|
Accr2g02045 |
717 |
SMART |
BRCT_7 |
487 |
573 |
IPR001357 |
- |
|
Accr2g02045 |
717 |
SMART |
BRCT_7 |
606 |
710 |
IPR001357 |
- |
|
Accr2g02045 |
717 |
Gene3D |
Zinc/RING finger domain, C3HC4 (zinc finger) |
330 |
456 |
IPR013083 |
- |
|
Accr2g02045 |
717 |
SUPERFAMILY |
BRCT domain |
497 |
584 |
IPR036420 |
- |
|
Accr2g02045 |
717 |
FunFam |
Breast cancer type 1 susceptibility protein homolog |
494 |
600 |
- |
- |